menu
    • menu

    Company profile for The Himalaya Drug Company

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    In the forests of Burma, a curious young man looked on, as villagers fed the roots of a local herb to calm a herd of agitated elephants. That man was Mr. M. Manal, the founder of Himalaya, and that herb was Rauwolfia Serpentina, the inspiration that led to the creation of Serpina®, the world's first natural antihypertensive drug, launched in 1934. Mr. Manal's dream of discovering the mysteries of nature began in the year 193...
    In the forests of Burma, a curious young man looked on, as villagers fed the roots of a local herb to calm a herd of agitated elephants. That man was Mr. M. Manal, the founder of Himalaya, and that herb was Rauwolfia Serpentina, the inspiration that led to the creation of Serpina®, the world's first natural antihypertensive drug, launched in 1934. Mr. Manal's dream of discovering the mysteries of nature began in the year 1930. He was determined to bring to people the promise of nature's healing power, harnessed through scientific research.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    The Himalaya Drug Companyindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Makali, Bengaluru - 562162
    Telephone
    Telephone
    1–800–208–1930
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://himalayawellness.in/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Experts: India's Ayush Ministry Driving Global Market Success
    Experts: India's Ayush Ministry Driving Global Market Success

    23 Dec 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=183187&sid=1

    PHARMABIZ
    23 Dec 2025
    Share Share
    Himalaya Wellness & Unicommerce Partner for Omnichannel Retail
    Himalaya Wellness & Unicommerce Partner for Omnichannel Retail

    28 Nov 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/himalaya-wellness-partners-with-unicommerce-to-drive-omnichannel-expansion/

    EXPRESSPHARMA
    28 Nov 2025
    Share Share
    Delhi HC Upholds Order Restraining Rajasthan Aushdhalaya
    Delhi HC Upholds Order Restraining Rajasthan Aushdhalaya

    07 Jul 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/delhi-hc-upholds-order-to-restrain-rajasthan-aushdhalaya-from-making-and-selling-medicines-under-liv-333-name/articleshow/122302549.cms

    ECONOMICTIMES
    07 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search